BNTX Intrinsic Value

Intrinsic Value of BNTX Overview

Secure instant access to premium content today
Get access

BNTX Historical Intrinsic Value

1W
1M
6M
YTD
1Y
3Y
5Y
10Y
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
$0.0$50.0$100.0$150.0$200.0$250.0$300.0$350.0$400.0$450.0Jan'21Jan'22Jan'23Jan'24Jan'25
Value Sense
Intrinsic Value
BNTX

BNTX Valuation Metrics

Crunching data... Almost there!

BNTX DCF Model

Crunching data... Almost there!

BNTX DCF Value

Crunching data... Almost there!

BNTX Earnings Power Value and Enterprise Value

Crunching data... Almost there!

BNTX Reverse DCF

Crunching data... Almost there!

Competing with BNTX Intrinsic Value

Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!

Intrinsic Valuation Tools

Wondering how to calculate intrinsic value of a stock? Use our intrinsic value tools to simplify complex valuation concepts and save time.
Investing armour 2024
50+ visuals to equip yourself with investing wisdom. Sign up to receive it for FREE

FAQ

What is the DCF value of BioNTech SE (BNTX)?

As of today, DCF Value of BioNTech SE is $225.1, which is undervalued by 83.2%, compared to the current market share price of $122.9

How was the DCF Value calculated?

Step 1: Calculating Intrinsic Enterprise Value DCF Value was calculated by estimating BioNTech SE future free cash flow and then discounting it, using a chosen discount rate to determine Intrinsic Enterprise Value of $0.0B Step 2: Balance Sheet Adjustments Intrinsic Equity Value is calculated by subtracting Balance Sheet items (Cash & Equivalents, Short-term investments and Total Debt) from previously calculated Intrinsic Enterprise Value. This Intrinsic Equity Value is then divided by the total number of outstanding shares of 0 to determine DCF Value of $225.1

What is the Relative value of BioNTech SE (BNTX)?

As of today, Relative Value of BioNTech SE is $102.9, which is overvalued by 16.3%, compared to the current market share price of $122.9

How was the Relative Value calculated?

Relative Value was calculated by applying various valuation multiples (EV/Revenue, EV/EBITDA, P/E etc.) to BioNTech SE financials to determine Relative Value of $102.9

What is BioNTech SE (BNTX) discount rate?

BioNTech SE current Cost of Equity is 8.0%, while its WACC stands at 8.0%. Cost of Equity is used to value equity, while discounting free cash flow to equity holders (such as Net Income or Free Cash Flow to Equity). Weighted Average Cost of Capital (WACC) is used to value the entire firm, while discounting cash flows available to both debt and equity holders (NOPAT or Free Cash Flow to the Firm)

How is Cost of Equity for BioNTech SE (BNTX) calculated?

The Cost of Equity represents the return a company must offer investors to compensate for the risk of investing in its stock. It's calculated using the Capital Asset Pricing Model (CAPM), which combines the risk-free rate, the stock's beta, and the equity risk premium (ERP). This model considers the inherent risk of investing in the stock compared to a risk-free investment and the market's overall risk. Cost of Equity = Risk-Free Rate + Beta x Effective Risk Premium (ERP) 8.0% = 4.8% + 0.7 x 4.6%

How is WACC for BioNTech SE (BNTX) calculated?

WACC, or Weighted Average Cost of Capital, is a calculation that reflects the average rate of return a company is expected to pay its security holders to finance its assets. It is a critical measure in financial analysis for valuing a company's entire operations. The WACC formula combines the costs of equity and debt, weighted by their respective proportions in the company's capital structure. WACC = Cost of Equity x Equity Weight in Total Capital + Cost of Debt x (1 - Effective Tax Rate) Debt Weight in Total Capital 8.0% = 8.0% x 0.8% + 3.3% x (1 - (24.8%)) x 99.2%